4//SEC Filing
Simms Michael J 4
Accession 0001209191-11-012468
CIK 0001344413other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:04 PM ET
Size
13.4 KB
Accession
0001209191-11-012468
Insider Transaction Report
Form 4
Simms Michael J
SVP, Operations & Manufact
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2011-02-22−175,000→ 0 totalExercise: $6.24From: 2009-02-25Exp: 2018-02-25→ Common Stock (175,000 underlying) - Award
Stock Option (right to buy)
2011-02-22+43,750→ 43,750 totalExercise: $1.23Exp: 2016-02-22→ Common Stock (43,750 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-02-22−25,989→ 0 totalExercise: $2.81From: 2009-01-02Exp: 2019-01-22→ Common Stock (25,989 underlying) - Award
Stock Option (right to buy)
2011-02-22+17,326→ 17,326 totalExercise: $1.23Exp: 2016-02-22→ Common Stock (17,326 underlying)
Footnotes (4)
- [F1]The option provided for vesting equal to 25% of such shares on February 25, 2009 with the remaining 75% of such shares vesting each succeeding monthly anniversary of such date in equal installments over the next 36 months.
- [F2]The option is fully vested.
- [F3]On February 22, 2011, the Issuer canceled, pursuant to the Issuer's option exchange program, outstanding options for shares of its common stock that were granted to the Reporting Person prior to January 21, 2011 with exercise prices greater than or equal to $2.37 per share that were tendered by the Reporting Person for exchange. In exchange, the Reporting Person received replacement options having an exercise price of $1.23 per share (the "Replacement Options") under the Issuer's 2005 Equity Incentive Plan. The Replacement Options expire five years after the date of grant.
- [F4]33% of the shares subject to each of the Replacement Options will vest and become exercisable one year after February 22, 2011, the date of grant, and the balance of the shares will vest and become exercisable in a series of 24 successive equal monthly installments thereafter, subject, in each case, to the Reporting Person's continued employment with the Issuer through such vesting dates. Notwithstanding the foregoing, if the Reporting Person's continued employment with the Issuer terminates within three months prior to, or 12 months following, the effective date of a change in control of the Issuer due to (i) an involuntary termination (excluding death or disability) without cause, or (ii) a voluntary termination for good reason, the vesting and exercisability of the shares subject to the applicable stock option will be accelerated in full as of the later of the change in control and such termination date.
Documents
Issuer
Alexza Pharmaceuticals Inc.
CIK 0001344413
Entity typeother
Related Parties
1- filerCIK 0001427117
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:04 PM ET
- Size
- 13.4 KB